Mmegi

Pharmaceuticals present $190m opportunity for growth, innovation

Shot in the arm: The COVID-19 pandemic exposed the need for countries such as Botswana to bulk up their pharmaceutical sectors PIC:  VCU NEWS
Shot in the arm: The COVID-19 pandemic exposed the need for countries such as Botswana to bulk up their pharmaceutical sectors PIC: VCU NEWS

A study into the potential of developing a pharmaceutical industry in the country has found that strategic investments in policy, skills development, and harnessing the country’s rich biodiversity, could transform the infant sector into a regional powerhouse.

The study was developed last year by the Botswana Investment and Trade Centre (BITC) in partnership with the European Union’s Africa RISE (Reform for Investment and Sustainable Economies) programme.

The study aims to help Botswana develop its pharmaceutical manufacturing capabilities while boosting its competitiveness at both local and regional levels. The consultancy team included three local experts from the University of Botswana who worked alongside the BITC team, reporting to a diverse reference group that validated the findings.

Editor's Comment
‘Fake’ drugs: A matter of life, truth and accountability

When claims of such gravity are made, especially by a sitting Assistant Minister they cannot be brushed aside, delayed, or treated as routine political noise. Even the Ombudsman has confirmed receipt of a report from a political party and a review of these complaints is now underway. That is a necessary first step. But it is only the beginning. The seriousness of the allegations demands urgency, transparency and clarity. The public is entitled to...

Have a Story? Send Us a tip
arrow up